Results 221 to 230 of about 187,553 (368)

In vivo evidence that erythropoietin protects neurons from ischemic damage.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1998
M. Sakanaka   +6 more
semanticscholar   +1 more source

A slow burn: Revisiting cross‐adaptation through long‐term heat acclimation

open access: yes
Experimental Physiology, EarlyView.
Elliott J. Jenkins, Michael Stembridge
wiley   +1 more source

Cyanide Beyond Toxicity: A Systematic Review of Its Effects on Vascular Function

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 137, Issue 5, November 2025.
ABSTRACT Cyanide is widely recognized for its potent toxicity, yet evidence shows that concentrations below 1 μM may enhance cytochrome c oxidase activity and have a regulatory function. Recent findings also demonstrate that mammalian cells, including endothelial cells, produce cyanide endogenously, where it can modulate mitochondrial bioenergetics ...
Elif Alan‐Albayrak, Ulf Simonsen
wiley   +1 more source

Effect of 2-h hypoxic exposure on resting hepcidin levels in young adults. [PDF]

open access: yesPhysiol Rep
Lin CA   +5 more
europepmc   +1 more source

SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6559-6566, November 2025.
Abstract Aims Iron deficiency anaemia (IDA) is a common comorbidity in patients with type 2 diabetes mellitus (T2DM). Sodium–glucose cotransporter‐2 inhibitors (SGLT2i) have been shown to modulate erythropoiesis and iron metabolism, but their association remains unclear.
Theresia Sarabhai, Karel Kostev
wiley   +1 more source

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.

open access: yesBlood, 2003
C. Heeschen   +9 more
semanticscholar   +1 more source

Barriers to adoption of biosimilar insulins in Europe: A mixed‐methods study

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6715-6726, November 2025.
Abstract Background Despite the introduction of biosimilar insulins to improve affordability and enhance patient access, their adoption remains limited in Europe. Objectives This study aims to (i) provide an up‐to‐date overview of EMA‐approved insulin products and their reimbursement status across selected European countries, and (ii) explore the key ...
Elif Car   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy